Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
J Am Heart Assoc 2022 Oct 07;[EPub Ahead of Print], GE Raskob, W Ageno, G Albers, CG Elliott, J Halperin, G Maynard, PG Steg, JI Weitz, J Albanese, Z Yuan, B Levitan, W Lu, EY Suh, T Spiro, C Lipardi, ES Barnathan, AC SpyropoulosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.